Uterine quiescence during pregnancy, until term, is required for successful completion of gestation by providing a tranquil environment for the growing fetus. Failure to maintain uterine relaxation until term results in preterm delivery, which is the leading cause of infant mortality and morbidity. Recent evidence suggests that nitric oxide (NO) is a potent mediator of smooth muscle relaxation. We initiated studies to examine if an L-arginine-NO-cGMP-relaxation system is present in the rat uterus and if it inhibits contractility. Our preliminary studies provide strong evidence for the presence of a NO-relaxation pathway in the rat uterus and suggest that this system might play a role in maintaining uterine quiescence during pregnancy. To extend these studies we propose to test the following hypotheses: a. A L-arginine NO-cGMP-pathway is present in the uterus and that it specifically inhibits uterine contractility. b. The NO-cGMP-relaxation pathway is upregulated during pregnancy. c. The generation of NO-cGMP and relaxation effects of NO-cGMP are hormonally regulated.
The specific aims of this study are: 1. To further establish the existence of a NO-cGMP-relaxation system in the uterus and determine if NO is produced in the uterus. For this we will use various agents to modulate the pathway and measure uterine contractility in vitro. 2. To localize nitric oxide synthase (NOS) activity in the uterine tissues and to ascertain which isoform(s) of NOS are present in this tissue. 3. To investigate whether the NO-cGMP-relaxation system is upregulated during pregnancy and if it is hormone regulated. 4. To examine the mechanisms involved in the NO-cGMP regulation of uterine contractility. 5. To ascertain whether manipulation of the NO-cGMP cascade during pregnancy will affect the pregnancy outcome. 6. To investigate the existence of NO-cGMP system in the human uterus and determine if the uterus reacts to this system differently in pregnant delivering, nondelivering and nonpregnant women. To accomplish these studies, we will use pharmacological studies of in vitro contractility measurement, biochemical assays for NO and cGMP production, arginine to citrulline conversion, histochemical localization and determine the isoform(s) of the NOS in the uterus. These studies will provide important information on the mechanisms through which uterine contractility is regulated during gestation and initiation of labor. Knowledge from these studies may provide the basis for designing appropriate therapeutic strategies to reduce preterm labor.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD030273-02
Application #
2202583
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1994-08-01
Project End
1998-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Fang, Li; Nowicki, Bogdan J; Urvil, Petri et al. (2004) Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun 72:2907-14
Chauhan, Madhu; Thota, Chandra S; Kondapaka, Sudhir et al. (2003) Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides 24:65-71
Dong, Y L; Vegiraju, S; Chauhan, M et al. (2003) Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization. Mol Hum Reprod 9:481-90
Dong, Yuan-Lin; Wimalawansa, Suril; Yallampalli, Chandrasekhar (2003) Effects of steroid hormones on calcitonin gene-related peptide receptors in cultured human myometrium. Am J Obstet Gynecol 188:466-72
Gangula, P R R; Dong, Y L; Wimalawansa, S J et al. (2002) Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)(8-37), a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth. Biol Reprod 67:624-9
Yallampalli, Chandrasekhar; Chauhan, Madhu; Thota, Chandra S et al. (2002) Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab 13:263-9
Lanlua, P; Gangula, P R; Taglialatela, G et al. (2001) Gestational changes in calcitonin gene-related peptide, nerve growth factor, and its receptors in rat dorsal root ganglia. Biol Reprod 65:1601-5
Gangula, P R; Zhao, H; Wimalawansa, S J et al. (2001) Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod 64:1776-83
Lanlua, P; Decorti, F; Gangula, P R et al. (2001) Female steroid hormones modulate receptors for nerve growth factor in rat dorsal root ganglia. Biol Reprod 64:331-8
Fang, L; Nowicki, B; Yallampalli, C (2001) Differential expression of uterine NO in pregnant and nonpregnant rats with intrauterine bacterial infection. Am J Physiol Regul Integr Comp Physiol 280:R1356-63

Showing the most recent 10 out of 32 publications